Everence Capital Management Inc Emergent Bio Solutions Inc. Transaction History

Everence Capital Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$11.0 - $21.45 $204,380 - $398,541	18,580 New	18,580 $219,000
Q4 2021 Jan 28, 2022	BUY	$33.11 - $55.01 $287,394 - $477,486	8,680 New	8,680 $377,000
Q3 2020 Oct 20, 2020	SELL	$81.91 - $134.94 $629,068 - $1.04 Million	-7,680 Closed	0 $0
Q2 2020 Jul 09, 2020	BUY	$54.33 - $89.52 $64,109 - $105,633	1,180 Added 18.15%	7,680 $641,000
Q2 2020 Jul 07, 2020	SELL	$54.33 - $89.52 $64,109 - $105,633	-1,180 Reduced 15.36%	6,500 $351,000
Q1 2020 Jul 09, 2020	BUY	$49.34 - $68.76 $58,221 - $81,136	1,180 Added 18.15%	7,680 $444,000
Q1 2019 May 06, 2019	BUY	$48.23 - $66.16 $122,504 - $168,046	2,540 Added 64.14%	6,500 $328,000
Q3 2018 Oct 22, 2018	BUY	$52.05 - $66.51 $206,118 - $263,379	3,960 New	3,960 $261,000
Q2 2018 Jul 26, 2018	SELL	$48.33 - $55.64 $191,386 - $220,334	-3,960 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$44.44 - $54.39 $175,982 - $215,384	3,960 New	3,960 $208,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $427M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.